Ipca Laboratories informs about outcome of the board meeting

24 Nov 2021 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations’), Ipca Laboratories has informed about the outcome of the meeting of the Board of Directors of the Company held today, November 24, 2021. The Board has approved the acquisition of 26.574% of the paid-up share capital of Lyka Labs and entering into a Joint Management Control Agreement with the Promoters of the said company. Lyka Labs is a company incorporated in the year 1976 under Companies Act, 1956 and is engaged in the business of manufacturing and marketing of injectables, lyophilized injectables and topical formulations. Consequent to this acquisition of shares, the Company has also, made a public announcement to acquire 26% additional equity shares of the said company from its public shareholders under the SEBI (SAST) Regulations, 2011. The required disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is enclosed.The Board Meeting started 8.15 am and concluded at 8.35 am.

The above information is a part of company’s filings submitted to BSE.

Ipca Laboratories Share Price

1459.30 2.15 (0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×